$GRC

Is Gorman Rupp (GRC) Fully Priced Following Its Strong Quarterly Results?

Simply Wall St reports Gorman-Rupp (GRC) drew renewed attention after its July 24 earnings release, citing higher Q2 sales and net income year over year. The stock trades at $81.19, with 90-day return 6.62%, YTD 68.65%, and 1-year total shareholder return 101.54%. Valuation centers on a 34.4x P/E versus a 25.7x fair P/E and a DCF fair value of $117.43.

Original reporting
Published Aug 3, 2026, 10:24 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 2:40 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Gorman Rupp (GRC) Fully Priced Following Its Strong Quarterly Results? — source image
Decision brief

The 30-second read

$GRCNeutralLow
01

Why it matters

The trading relevance comes from how valuation could re-rate after earnings: either support from earnings quality or downside from multiple compression if cash generation disappoints.

02

Market read

For traders, the article is a valuation lens rather than a new catalyst, emphasizing potential overvaluation risk despite strong reported results.

03

What to watch

The article does not provide segment/order backlog, cash conversion, or guidance details, which are key to judging whether the P/E premium is justified.

Relevance 4/10Novelty 3/10Timing: After-hours/ongoing post–July 24 earnings valuation discussion.

Background

Simply Wall St discusses Gorman-Rupp’s post–July 24 earnings momentum and compares valuation metrics (P/E and DCF) to internal fair value and peers.

Company-level read

Ticker impact

$GRCNeutralMedium confidence
Context

The article revisits Gorman-Rupp’s July 24 earnings, then frames valuation with a 34.4x P/E versus a 25.7x fair estimate and DCF value of $117.43.

Expected impact

Near-term bias is mixed: momentum is supported by strong results, but the article highlights overvaluation risk versus fair P/E and analyst-target proximity.

Evidence & confidence

No new earnings numbers are disclosed beyond referencing the July 24 release; the text mainly updates how investors might price the already-reported quarter using P/E and DCF comparisons.

Market effects

Limited sector spillover; the piece is primarily single-name valuation framing for industrial machinery/supply-chain investors.

None indicated.

None indicated.

Counterpoint

The DCF implies the stock is materially undervalued versus $117.43, suggesting the P/E premium may reflect durable earnings quality rather than overpaying.

Key entities

  • Gorman-Rupp

    Subject of the article; valuation is discussed using P/E (34.4x), a fair P/E estimate (25.7x), and a DCF value ($117.43).

Related articles

$GRCMed

Gorman-Rupp posts record results, extends dividend streak

Gorman-Rupp reported record Q2 results for the quarter ended June 30. Net sales rose to $186.1 million from $179.0 million, and net income increased to $19.4 million, or 74 cents per share. Operating income reached $30.4 million. The board declared a 19-cent dividend, the 306th consecutive quarterly payout, and announced a CFO transition effective Oct. 1.

$GRCMed

GORMAN RUPP CO (GRC): Results of Operations and Financial Condition

GORMAN RUPP CO (GRC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 grc-ex99.htm EX-99 EX-99 Exhibit 99 GORMAN-RUPP REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS Mansfield, Ohio – July 24, 2026 – The Gorman-Rupp Company (NYSE: GRC) reports financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Highlights • Recor

$GRCMedAI 8/10

Why is Gorman-Rupp stock climbing today? By Investing.com

Gorman-Rupp (GRC) shares rose about 3% pre-open after the company reported Q2 2026 results. EPS was $0.74 vs $0.71 expected. Revenue was $186.1M, slightly below ~$188.1M consensus. Adjusted EBITDA was $38.2M vs $35.5M, operating margin rose to 16.3%, free cash flow margin to 19.8%, debt fell $33M, and backlog rose 6.8% to $239.7M. It also declared a $0.19 dividend and announced a CFO transition.

$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).